Karen Burton compensation by year
STERIS Summary Compensation Table · the one fiscal year held| Component | FY2026 |
|---|---|
| Salary | $530,762 |
| Bonus | $0 |
| Stock awards | $1,042,037 |
| Option awards | $1,111,148 |
| Non-equity incentive | $491,493 |
| Pension and deferred compensation | $0 |
| All other | $16,977 |
| Total | $3,192,417 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STERIS plc DEF 14A filed June 11, 2026, accession 0001193125-26-267599, and prior-year filings. Open the filing on EDGAR.
How this page was built: the STERIS plc filed document, accession 0001193125-26-267599. Every figure is read from that document and cited to the page and table it appears in. Filed June 11, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 2,349 | $519,434 | — |
| RSU | 1,953 | $431,867 | — |
| RSU | 612 | $135,332 | — |
| RSU | 340 | $75,184 | — |
| RSU | 225 | $49,754 | — |
| Option | 1,025 | — | $250.06 |
| Option | 1,910 | — | $219.97 |
| Option | 2,358 | — | $251.34 |
| Option | 6,944 | — | $267.66 |
| Option | 8,356 | — | $265.43 |
Per the Outstanding Equity Awards at Fiscal Year-End table in STERIS plc's FY2026 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2026 proxy (filed June 11, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-01 | Tax withholding | — | 228 | $0.00 | 12,956 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
STERIS’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Daniel Carestio | President and Chief Executive Officer | $11,508,522 |
| Karen Burton · this page | Senior Vice President and Chief Financial Officer | $3,192,417 |
| J. Adam Zangerle | Senior Vice President, General Counsel and Company Secretary | $2,954,465 |
| Cary Majors | Senior Vice President and President, Healthcare | $2,450,424 |
| Michael Tokich | Senior Financial Advisor (Former Senior Vice President and Chief Financial Officer) | $2,229,993 |
| Mary Clare Fraser | Senior Vice President and Chief Human Resources Officer | $2,073,722 |
Karen Burton's compensation dossier, STERIS
You have read Karen Burton's totals and holdings. The dossier adds each equity grant STERIS disclosed for Karen Burton and STERIS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full STERIS compensation record
free company briefThis page is one person within STERIS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the STERIS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order STERIS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STERIS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order STE
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.